IL6 and chronic obstructive pulmonary disease: Studies have shown that patients with COPD have a systemic inflammatory response, including the activation of inflammatory cells and increased levels of multiple circulating inflammatory factors, such as tumour necrosis factor-α (TNF-α), interleukin (IL)-1, IL-6, IL-8, and C-reactive protein (Huang et al., 2016).